Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatin in Type 2 Diabetes
NCT07852988Phase 4Recruiting
- Sponsor
- Silesian Center for Heart Diseases
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 4 trial of pancreatin in type 2 diabetes mellitus (T2DM), sponsored by Silesian Center for Heart Diseases. Started Aug 2026; status: recruiting.
02
Drugs
pancreatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07852988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07852988.